Cargando…

Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer

The role of adjuvant ovarian suppression or ablation (OS/OA) in premenopausal women with hormone receptor-positive breast cancer remains controversial. The purpose of our study was to examine which patients might benefit from the addition of OS/OA to tamoxifen. We analyzed the data of 2065 premenopa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Cong, Peng, Roujun, Cao, Ye, Wang, Shusen, Shi, Yanxia, An, Xin, Xu, Fei, Yuan, Zhongyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750981/ https://www.ncbi.nlm.nih.gov/pubmed/26866810 http://dx.doi.org/10.1371/journal.pone.0148849

Ejemplares similares

Goserelin Ovarian Ablation Failure in Premenopausal Women With Breast Cancer
por: Gupta, Aanchal, et al.
Publicado: (2021)

Role of Ovarian Function Suppression in Premenopausal Women with Early Breast Cancer
por: Park, Woo-Chan
Publicado: (2016)

Ovarian reserve in premenopausal women with breast cancer
por: Zong, Xiangyun, et al.
Publicado: (2022)

Selective Estrogen Receptor Modulator-Associated Nonalcoholic Fatty Liver Disease Improved Survival in Patients With Breast Cancer: A Retrospective Cohort Analysis
por: Zheng, Qiufan, et al.
Publicado: (2015)

Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China
por: Xue, Cong, et al.
Publicado: (2012)

Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor
por: Jordan, Jennifer H, et al.
Publicado: (2021)

Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer
por: Qiu, Lin, et al.
Publicado: (2016)

HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients
por: Qin, Tao, et al.
Publicado: (2013)

Effects of soy foods on ovarian function in premenopausal women
por: Wu, A H, et al.
Publicado: (2000)

Ovarian Inguinal Hernia in Premenopausal Women: A Case Report
por: Samantroy, Subhra, et al.
Publicado: (2021)

Awareness of the Causes Leading to Surgical Ablation of Ovarian Function in Premenopausal Breast Cancer—A Single-Center Analysis
por: Oliveira, Joana Correia, et al.
Publicado: (2021)

Tamoxifen-induced ovarian hyperstimulation during premenopausal hormonal therapy for breast cancer in Japanese women
por: Yamazaki, Rena, et al.
Publicado: (2015)

Adjuvant ovarian suppression for premenopausal hormone receptor-positive breast cancer: A network meta-analysis
por: Jiang, Mengjie, et al.
Publicado: (2021)

Diagnostic challenge for ovarian malignant melanoma in premenopausal women: Primary or metastatic?
por: Sbitti, Yassir, et al.
Publicado: (2011)

Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma
por: Nasioudis, Dimitrios, et al.
Publicado: (2017)

Postoperative outcomes of ovarian preserving surgery in premenopausal women with adnexal torsion
por: Choi, Euna, et al.
Publicado: (2023)

Ovarian function and ovarian blood supply following premenopausal abdominal hysterectomy
por: Abdelazim, Ibrahim A., et al.
Publicado: (2015)

Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
por: Lu, Yen-Shen, et al.
Publicado: (2021)

Ovarian hormones and reproductive risk factors for breast cancer in premenopausal women: the Norwegian EBBA-I study
por: Iversen, A., et al.
Publicado: (2011)

Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer
por: Anderson, Richard A., et al.
Publicado: (2022)

Ovarian Ablation Using Goserelin Improves Survival of Premenopausal Patients with Stage II/III Hormone Receptor-Positive Breast Cancer without Chemotherapy-Induced Amenorrhea
por: Zhou, Juan, et al.
Publicado: (2015)

Tamoxifen with ovarian function suppression versus tamoxifen alone as an adjuvant treatment for premenopausal breast cancer: a meta-analysis of published randomized controlled trials
por: Yan, Shunchao, et al.
Publicado: (2015)

Ovarian cancer risk in premenopausal and perimenopausal women treated with Tamoxifen: a case–control study
por: Swerdlow, A J, et al.
Publicado: (2007)

Ovarian preservation for premenopausal women with early-stage endometrial cancer: a Chinese retrospective study
por: Lyu, Tianjiao, et al.
Publicado: (2019)

Prediction of ovarian function in premenopausal breast cancer patients with amenorrhoea after chemotherapy: a simple clinical score
por: Li, Xiao Shi, et al.
Publicado: (2016)

Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases
por: MADEDDU, CLELIA, et al.
Publicado: (2014)

The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast Cancer
por: Blondeaux, Eva, et al.
Publicado: (2021)

Hyperprolactinaemia is common in Chinese premenopausal women with breast diseases
por: Zhu, Jiang, et al.
Publicado: (2023)

Cavin3 Suppresses Breast Cancer Metastasis via Inhibiting AKT Pathway
por: An, Xin, et al.
Publicado: (2020)

Discrepancies in estradiol levels in a premenopausal woman receiving abemaciclib despite ovarian function suppression and bilateral salpingo-oophorectomy
por: Kessler, Alaina J., et al.
Publicado: (2023)

Differential analysis of quantitative proteome and acetyl-proteome profiling between premenopausal and postmenopausal ovarian tissues
por: Yi, Jinling, et al.
Publicado: (2018)

Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study
por: Ozaki, Yukinori, et al.
Publicado: (2018)

Birth characteristics of premenopausal women with breast cancer.
por: Le Marchand, L., et al.
Publicado: (1988)

Genomic signature of parity in the breast of premenopausal women
por: Santucci-Pereira, Julia, et al.
Publicado: (2019)

Lipidome of mammographic breast density in premenopausal women
por: Getz, Kayla R., et al.
Publicado: (2023)

Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth.
por: Cohen, I., et al.
Publicado: (1994)

Adjuvant ovarian function suppression and cognitive function in women with breast cancer
por: Phillips, Kelly-Anne, et al.
Publicado: (2016)

Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis
por: Shen, Yan-Wei, et al.
Publicado: (2015)

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
Publicado: (2022)

Physical activity and risk of breast cancer in premenopausal women
por: Colditz, G A, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_otv098grna498vof7h3u27kb60